- Country: Czech Republic
- Summary: Lp with Filgrasti
- CZT Ref No: 53430960
- Deadline: 21 Jun 2021
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: CZK 20184850.00
- Notice Type: Tender
- Document Ref. No.: 260601-2021
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Document Type: CONTRACT NOTICE
TITLE: LP containing Filgrastim
Reference Number: 2021 / s 099-260601
CONTRACT TYPE: Supplies
Estimated Value: 20184850.00 - CZK
Description: The subject of the contract is the continuous supply of medicinal products containing filgrastim for 4 years according to the current needs of the contracting authority.
33652000 - Antineoplastic and ImmunModulating Agents
Authority Type: National or Federal Agency / Office
Type of Procedure: Open Procedure
Regulation: European Union, With Participation by GPA COUNTRIES
BID Type: Submission for All Lots
DOC TITLE: Antineoplastic and ImmunModulating Agents
DISPATCH DATE: 2021-05-20
Publish Date: 2021-05-25
Submission date: 2021-06-21 - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINLp with Filgrasti - Czech Tender
The FACULTY HOSPITAL HRADEC KRÁLOVÉ, a Government sector organization in Czech Republic, has announced a new tender for Lp with Filgrasti. This tender is published on CzechTenders under CZT Ref No: 53430960 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2021-06-21.
The estimated tender value is CZK 20184850.00, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
